Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1194)
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
5,526
Price
$28.37
Total Value
$156.77K
Shares Held After
280,381
% of Holdings
1.9%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
312
Price
$29.56
Total Value
$9.22K
Shares Held After
385,825
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
5,460
Price
$28.37
Total Value
$154.90K
Shares Held After
386,137
% of Holdings
1.4%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
9,250
Price
$27.50
Total Value
$254.38K
Shares Held After
285,907
% of Holdings
3.1%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
9,180
Price
$27.50
Total Value
$252.45K
Shares Held After
391,597
% of Holdings
2.3%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
697
Price
$30.08
Total Value
$20.97K
Shares Held After
1,614,993
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
683
Price
$30.08
Total Value
$20.54K
Shares Held After
176,248
% of Holdings
0.4%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
311
Price
$29.56
Total Value
$9.19K
Shares Held After
1,615,690
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
296
Price
$29.56
Total Value
$8.75K
Shares Held After
176,931
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
5,427
Price
$28.37
Total Value
$153.96K
Shares Held After
1,616,001
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
3,908
Price
$28.29
Total Value
$110.56K
Shares Held After
177,227
% of Holdings
2.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
9,136
Price
$27.50
Total Value
$251.24K
Shares Held After
1,621,428
% of Holdings
0.6%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
9,030
Price
$27.50
Total Value
$248.32K
Shares Held After
181,135
% of Holdings
4.7%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
20,000
Price
$45.00
Total Value
$900.00K
Shares Held After
111,473
% of Holdings
15.2%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
20,000
Price
$45.00
Total Value
$900.00K
Shares Held After
105,211
% of Holdings
16.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
884
Price
$23.61
Total Value
$20.87K
Shares Held After
126,689
% of Holdings
0.7%
Travere Therapeutics, Inc. (TVTX)
Meckler Jeffrey A — Director
Shares
8,000
Price
$45.00
Total Value
$360.00K
Shares Held After
87,500
% of Holdings
8.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
7,372
Price
$23.27
Total Value
$171.54K
Shares Held After
127,573
% of Holdings
5.5%
Arcutis Biotherapeutics, Inc. (ARQT)
Watanabe Todd — Director
Shares
3,172
Price
$23.61
Total Value
$74.89K
Shares Held After
720,755
% of Holdings
0.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Vairavan Latha — SVP Chief Financial Officer
Shares
1,341
Price
$23.61
Total Value
$31.66K
Shares Held After
86,413
% of Holdings
1.5%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's Title: EVP, Chief Medical Officer
Shares
684
Price
$23.61
Total Value
$16.15K
Shares Held After
120,466
% of Holdings
0.6%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
2,466
Price
$18.00
Total Value
$44.39K
Shares Held After
1,156,457
% of Holdings
0.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
61
Price
$18.00
Total Value
$1.10K
Shares Held After
8,450
% of Holdings
0.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
6,241
Price
$18.00
Total Value
$112.34K
Shares Held After
4,933,196
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
3,136
Price
$18.00
Total Value
$56.45K
Shares Held After
1,574,270
% of Holdings
0.2%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
264
Price
$2.34
Total Value
$618.02
Shares Held After
506,997
% of Holdings
0.1%
IONIS PHARMACEUTICALS INC (IONS)
LOSCALZO JOSEPH — Director
Shares
17,781
Price
$75.58
Total Value
$1.34M
Shares Held After
36,330
% of Holdings
32.9%
IONIS PHARMACEUTICALS INC (IONS)
LOSCALZO JOSEPH — Director
Shares
59,508
Price
$74.90
Total Value
$4.46M
Shares Held After
54,111
% of Holdings
52.4%
Celcuity Inc. (CELC)
Dalvey David — Director
Shares
25,000
Price
$140.68
Total Value
$3.52M
Shares Held After
65,000
% of Holdings
27.8%
Tectonic Therapeutic, Inc. (TECX)
Ruddy Marcella K. — Chief Medical Officer
Shares
1,065
Price
$30.00
Total Value
$31.95K
Shares Held After
67,682
% of Holdings
1.5%
INSMED Inc (INSM)
Lewis William — Director
Shares
381
Price
$139.60
Total Value
$53.19K
Shares Held After
301,185
% of Holdings
0.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,247
Price
$139.09
Total Value
$173.45K
Shares Held After
301,566
% of Holdings
0.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,721
Price
$137.86
Total Value
$375.12K
Shares Held After
302,813
% of Holdings
0.9%
INSMED Inc (INSM)
Lewis William — Director
Shares
5,318
Price
$137.01
Total Value
$728.62K
Shares Held After
305,534
% of Holdings
1.7%
INSMED Inc (INSM)
Lewis William — Director
Shares
599
Price
$135.18
Total Value
$80.97K
Shares Held After
310,852
% of Holdings
0.2%
INSMED Inc (INSM)
Lewis William — Director
Shares
433
Price
$134.18
Total Value
$58.10K
Shares Held After
311,451
% of Holdings
0.1%
Celcuity Inc. (CELC)
Buller Richard E — Director
Shares
365
Price
$143.24
Total Value
$52.28K
Shares Held After
6,760
% of Holdings
5.1%
Celcuity Inc. (CELC)
Buller Richard E — Director
Shares
2,825
Price
$142.04
Total Value
$401.25K
Shares Held After
7,125
% of Holdings
28.4%
Celcuity Inc. (CELC)
Buller Richard E — Director
Shares
2,301
Price
$141.03
Total Value
$324.50K
Shares Held After
9,950
% of Holdings
18.8%
Celcuity Inc. (CELC)
Buller Richard E — Director
Shares
1,670
Price
$139.58
Total Value
$233.10K
Shares Held After
12,251
% of Holdings
12.0%
Celcuity Inc. (CELC)
Buller Richard E — Director
Shares
550
Price
$139.00
Total Value
$76.45K
Shares Held After
13,921
% of Holdings
3.8%
Celcuity Inc. (CELC)
Buller Richard E — Director
Shares
1,289
Price
$137.00
Total Value
$176.59K
Shares Held After
14,471
% of Holdings
8.2%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
2,111
Price
$102.88
Total Value
$217.18K
Shares Held After
324,879
% of Holdings
0.6%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
17,353
Price
$102.10
Total Value
$1.77M
Shares Held After
326,990
% of Holdings
5.0%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
7,429
Price
$101.48
Total Value
$753.89K
Shares Held After
344,343
% of Holdings
2.1%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
1,408
Price
$99.77
Total Value
$140.48K
Shares Held After
351,772
% of Holdings
0.4%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
1,699
Price
$98.54
Total Value
$167.42K
Shares Held After
353,180
% of Holdings
0.5%
Verastem, Inc. (VSTM)
Paterson Dan — Director
Shares
806
Price
$5.82
Total Value
$4.69K
Shares Held After
612,113
% of Holdings
0.1%
Axsome Therapeutics, Inc. (AXSM)
Jacobson Mark L. — Chief Operating Officer
Shares
4,517
Price
$227.94
Total Value
$1.03M
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
72,884
Price
$6.80
Total Value
$495.61K
Shares Held After
198,890
% of Holdings
26.8%
Showing 751–800 of 1194 transactions (page 16 of 24)